Mark Olfson, MD, MPH | Psychiatrist.com

Original Research

Heterogeneity in the Timing of Suicide Attempt Onset

April 7, 2020

Research suggests substantial age differences in suicide and suicide attempt rates. To better understand this heterogeneity, this study compared psychiatric, family history, and sociodemographic characteristics among 4 suicide attempter...

Hugo Peyre, Nicolas Hoertel, Frédéric Limosin, et al

Original Research

Model of Prescription Opioid Use Disorder

December 3, 2019

Prior research has identified several risk factors for prescription opioid use disorder (POUD). The authors attempted to develop a conceptual model for POUD based on an existing model for...

Carlos Blanco, Mark Olfson, Shang-Min Liu, et al

Original Research

Treatment of Common Mental Disorders in the US

May 28, 2019

When patients present for treatment of anxiety or mood disorders, do you consider whether there is also an untreated substance use disorder? Check out these data on disorder prevalence...

Carlos Blanco, Mark Olfson, Bridget F. Grant, et al

Commentary

Treatment-Resistant Schizophrenia Guideline

March 5, 2019

Read expert commentary on guidelines for treatment-resistant schizophrenia (TRS) to make more informed treatment decisions.

Mark Olfson, John M. Kane, Ofer Agid, et al

Original Research

Aging, Psychiatric Disorders, and Suicide Attempt

October 9, 2018

Psychiatric disorders often co-occur, and comorbidity patterns as well as suicide risk vary across the lifespan. Read this article to learn if suicide attempt risk in older and younger...

Nicolas Hoertel, Frédéric Limosin, Rachel Pascal de Raykeer, et al

Original Research

Insomnia and Impaired Quality of Life

September 11, 2018

Insomnia has been linked to several medical conditions, but the relationship between insomnia and these conditions can be unclear. Read this article to learn more about the connection between...

Carlos Blanco, Mark Olfson, Melanie Wall, et al

Original Research

Predictors of Suicide Attempt in Depressed Individuals

July 31, 2018

Many individual factors influence risk of suicide attempt. How can these disparate factors be understood in light of each other? Read this article to learn about a comprehensive model...

Nicolas Hoertel, Frédéric Limosin, Carlos Blanco, et al

Letter to the Editor

Dr Correll and Colleagues Reply

October 25, 2017

Leslie Citrome, Mark Olfson, John M. Kane, et al

Original Research

Does ADHD Diagnosis at Preschool Age Affect Treatment?

August 23, 2017

When children as young as 3 years old are prescribed anticonvulsants, antipsychotics, or psychotropic polypharmacy for their first diagnosis of ADHD, what is the trajectory of treatment in subsequent...

Mark Olfson, Christoph U. Correll, Tobias Gerhard, et al

Original Research

Clozapine and Blood Monitoring—Is Less Better?

July 18, 2017

In 2015, the FDA removed WBC monitoring altogether and reduced the threshold for ANCs before interruption of clozapine treatment was required. The current study looks at almost 250 clozapine-treated...

Mark Olfson, Christoph U. Correll, Ryan S. Sultan, et al

Original Research

Antipsychotic Medications in Adult Depression

July 5, 2017

Antipsychotic medications are increasingly prescribed to treat depression. But is this use always warranted? Read the article by Gerhard and colleagues to learn how often antipsychotics are prescribed in...

Mark Olfson, Christoph U. Correll, Tobias Gerhard, et al

Article

Mood Disorders and Antipsychotic Treatment in Youth

March 29, 2017

The increasing overlap of mood disorders and antipsychotic use in youth is a growing area of concern. This meta-analysis examined the current findings on the frequency of mood disorders...

Mark Olfson, Christoph U. Correll, Tobias Gerhard, et al

« 1 2 3 4 5 »